Germany’s Merck has completed the acquisition of US biopharmaceutical CDMO Exelead for $780 million in cash following the fulfillment of all closing conditions. The...
After several delays, Sanofi and GlaxoSmithKline are preparing to submit data to regulatory authorities to support approval of their adjuvanted protein vaccine against...
Sweden’s Recipharm is acquiring US CDMO Arranta Bio for an undisclosed sum. The deal, expected to close around the end of March, establishes a strong US presence for...
Global drug development and manufacturing accelerator Quotient Sciences has integrated drug substance into its Translational Pharmaceutics platform. The newly integrated...
Arkema is buying Shanghai Zhiguan Polymer Materials (PMP), a Chinese company that specializes in reactive hot-melt polyurethane (HMPUR) adhesives for the consumer...
British pharmaceuticals major GlaxoSmithKline (GSK) is now proceeding full speed ahead with plans to spin off its consumer health unit. The procedure is being...
Belgian chemicals and plastics giant Solvay is expanding its US portfolio of sulfone products to meet growing demand from what it says is a growing global base for...
Under the name Mark Cuban Cost Plus Drugs Company (MCCPD), the billionaire US investor of the same name is backing an online pharmacy offering what he says are more than...